Robot-assisted laparoscopic augmentation ileocystoplasty for neurogenic bladder: case report and structured literature review
- 1Department of Pediatric Surgery, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Department of Neurology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Abstract
Background: Bladder augmentation is generally reserved for selected patients failing conservative management or with unsafe storage pressures/compliance for neurogenic bladder (NGB) patients. The robotic-assisted laparoscopic approach for urinary issues has gained attention. This study evaluates the feasibility and safety of robot-assisted laparoscopic augmentation ileocystoplasty (RALAI) in treating NGB.
Methods: We present a case study of an 8.7-year-old male patient diagnosed with NGB, characterized by a preoperative bladder capacity of 198 ml, compliance of 13.6 ml/cm H2O, maximum detrusor pressure of 24 cm H2O, and a post-void residual volume of 250 ml. The patient underwent RALAI with the creation of a Mitrofanoff conduit. Subsequently, we conducted a comprehensive literature review on RALAI for NGB patients, covering the period from January 1, 2004, to December 31, 2024, utilizing databases such as PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang. The search employed keywords including “neurogenic bladder,” “ileocystoplasty,” and “robot.”
Measurements: The primary objective was to ascertain the surgical success rate of RALAI without conversion to open surgery. Secondary objectives included assessing complications within 90 days postoperatively, such as stomal complications, intestinal issues, and infections.
Results: The RALAI procedure was completed without conversion to open surgery in 86/92 patients (93.5%, 95% CI 88.4–98.5%), with a conversion rate of 6.5% (95% CI 1.6–11.4%). No intraoperative complications (e.g., visceral injury, hemorrhage or anesthetic events) directly attributable to the surgical technique were recorded). In the pooled cohort of 92 patients, the RALAI procedure demonstrated favorable patient-centred outcomes: postoperative bladder capacity increased substantially in the majority of reported cases; the rate of early postoperative complications was 38.0% (95% CI 28.1–48.0%), with 13.0% (95% CI 6.2–19.9%) requiring secondary surgical revision. Urinary tract infections occurred in 14.1% of patients. In our own index case, the patient achieved bladder capacity of 380 ml and social continence, resumed intermittent catheterization and spontaneous voiding, and remained free of urinary tract infections (UTIs) and bladder stones at 3 years.
Conclusions: Our findings indicate that RALAI is a feasible minimally invasive option for selected NGB patients, with a conversion rate of approximately 6.5%. However, the true value of the procedure should be assessed by patient-centred outcomes, which our pooled data suggest are promising.
Related
- Morquio A syndrome associated with bilateral hydroureteronephrosis and neurogenic bladder: a rare case report and review of the literature.
- Bacteroides fragilis Abscess Associated With Fat Necrosis Following Breast Augmentation With Autologous Fat Grafting: A Case Report With Review of the Literature.
- Clinical Presentation of, Treatment Approaches for, and the Impact of Social Determinants of Health on Pediatric Catatonia: A Structured Qualitative Synthesis and Targeted Literature Review.
- Neurological paraneoplastic syndromes in patients with breast and gynecological cancer—a case series and structured literature review
- Global Trends and Perspectives of Auriculotherapy on Pain Relief: A Bibliometric and Structured Literature Review
BibTeX
@article{you2026robotassisted,
title = {{Robot-assisted laparoscopic augmentation ileocystoplasty for neurogenic bladder: case report and structured literature review}},
author = {Jia You and Cheng Lan and Xu-fei Duan and Hai-tao Chen},
journal = {Frontiers in Surgery},
year = {2026},
month = oct,
doi = {10.3389/fsurg.2026.1767111},
url = {https://doi.org/10.3389/fsurg.2026.1767111},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Robot-assisted laparoscopic augmentation ileocystoplasty for neurogenic bladder: case report and structured literature review
AU - Jia You
AU - Cheng Lan
AU - Xu-fei Duan
AU - Hai-tao Chen
PY - 2026
DA - 2026/10/22
JO - Frontiers in Surgery
DO - 10.3389/fsurg.2026.1767111
UR - https://doi.org/10.3389/fsurg.2026.1767111
AB - Background: Bladder augmentation is generally reserved for selected patients failing conservative management or with unsafe storage pressures/compliance for neurogenic bladder (NGB) patients. The robotic-assisted laparoscopic approach for urinary issues has gained attention. This study evaluates the feasibility and safety of robot-assisted laparoscopic augmentation ileocystoplasty (RALAI) in treating NGB. Methods: We present a case study of an 8.7-year-old male patient diagnosed with NGB, characterized by a preoperative bladder capacity of 198 ml, compliance of 13.6 ml/cm H2O, maximum detrusor pressure of 24 cm H2O, and a post-void residual volume of 250 ml. The patient underwent RALAI with the creation of a Mitrofanoff conduit. Subsequently, we conducted a comprehensive literature review on RALAI for NGB patients, covering the period from January 1, 2004, to December 31, 2024, utilizing databases such as PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang. The search employed keywords including “neurogenic bladder,” “ileocystoplasty,” and “robot.” Measurements: The primary objective was to ascertain the surgical success rate of RALAI without conversion to open surgery. Secondary objectives included assessing complications within 90 days postoperatively, such as stomal complications, intestinal issues, and infections. Results: The RALAI procedure was completed without conversion to open surgery in 86/92 patients (93.5%, 95% CI 88.4–98.5%), with a conversion rate of 6.5% (95% CI 1.6–11.4%). No intraoperative complications (e.g., visceral injury, hemorrhage or anesthetic events) directly attributable to the surgical technique were recorded). In the pooled cohort of 92 patients, the RALAI procedure demonstrated favorable patient-centred outcomes: postoperative bladder capacity increased substantially in the majority of reported cases; the rate of early postoperative complications was 38.0% (95% CI 28.1–48.0%), with 13.0% (95% CI 6.2–19.9%) requiring secondary surgical revision. Urinary tract infections occurred in 14.1% of patients. In our own index case, the patient achieved bladder capacity of 380 ml and social continence, resumed intermittent catheterization and spontaneous voiding, and remained free of urinary tract infections (UTIs) and bladder stones at 3 years. Conclusions: Our findings indicate that RALAI is a feasible minimally invasive option for selected NGB patients, with a conversion rate of approximately 6.5%. However, the true value of the procedure should be assessed by patient-centred outcomes, which our pooled data suggest are promising.
SN - 2296-875X
ER -